We observed HLA associations in patients with nasopharyngeal carcinoma from northern China. There was an increased risk of nasopharyngeal carcinoma associated with HLA-B35 and a difference in the HLA association between patients with early- and late-onset disease. The frequency of B35 was significantly higher in patients than in control subjects, especially in early-onset patients (less than 30 years old). Late-onset patients had a higher frequency of DR2 as compared with normal subjects.
TerasakiPIBernocoDParkMSOzturkGIwakiY. Microdroplet testing for HLA-A, -B, -C and -DR antigens. Am J Clin Pathol1978; 69: 103–20.
2.
CuiSHLinY. Correlation between nasopharyngeal carcinoma and HLA phenotype. Zhong Hua Zhong Liu Za Zhi1982; 4: 249–53.
3.
OuBXRuanHYFangYLiuLMLiZQZhangF. Study on association between HLA-A, B, C, DR and nasopharyngeal carcinoma (NPC) in Guangzhou area. Ai Zheng1985; 4: 5–7.
4.
ChanSHDayNEKunaratnamNChiaKBSimonsMJ. HLA and nasopharyngeal carcinoma in Chinese — A further study. Int J Cancer1983; 32: 171–6.
5.
ChanSHChewCTPrasadUWeeGBSrinivasanNKunaratnamN. HLA and nasopharyngeal carcinoma in Malays. Br J Cancer1985; 51: 389–92.
6.
HeraitPTurszTGuillardMY. HLA-A, -B and -DR antigen in North African patients with nasopharyngeal carcinoma. Tissue Antigens1983; 22: 335–41.
